Overview

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

Status:
Terminated

Trial end date:
2014-06-24

Target enrollment:

Participant gender:

Summary

Study evaluating the efficacy and safety of intravenous (IV) ferumoxytol compared with oral iron for the treatment of pediatric participants with chronic kidney disease (CKD).

Phase:

Phase 3

Details

Lead Sponsor:

AMAG Pharmaceuticals, Inc.

Treatments:

Ferrosoferric Oxide
Ferrous fumarate
Iron